Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry

被引:207
作者
Hopkin, Robert J. [1 ,3 ]
Bissler, John [2 ,3 ]
Banikazemi, Maryam [4 ,5 ]
Clarke, Lorne [6 ]
Eng, Christine M. [7 ]
Germain, Dominique P. [8 ]
Lemay, Roberta [9 ]
Tylki-Szymanska, Anna [10 ]
Wilcox, William R. [11 ,12 ]
机构
[1] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA
[2] Cincinnati Childrens Hosp, Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH 45229 USA
[3] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA
[4] NYU, Dept Neurol, New York, NY 10016 USA
[5] NYU, Dept Pediat, New York, NY 10016 USA
[6] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada
[7] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[8] Univ Versailles, Hop Raymond Poincare, AP HP, F-92380 St Quentin en Yvelines, Garches, France
[9] Genzyme Corp, Biomed Operat, Cambridge, MA 02142 USA
[10] Klin Chorob Metabol, Dept Pediat, PL-04736 Warsaw, Poland
[11] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[12] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA
关键词
D O I
10.1203/PDR.0b013e318183f132
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Fabry disease is an X-linked lysosomal disease caused by deficiency of alpha-galactosidase A. Signs and symptoms of Fabry disease occurring during, childhood and adolescence were characterized in 352 Fabry Registry patients. At enrollment (median age 12 year), 77% of males and 51% of females reported symptoms. The median age of symptom onset was 6 year in males and 9 year in females. The most frequent symptom, neuropathic pain, was reported by 59% of males (median age 7 year) and 41% of females (median age 9 year). Gastrointestinal symptoms were reported by 18% of children (median age 5 year in males and 9.5 year in females). Males exhibited height and weight values below the US 50th percentile. Females had weight values above the US 50th percentile, A few patients had serious renal and cardiac manifestations, stage 2 or 3 chronic kidney disease (n = 3), arrhythmia (n = 9), and left ventricular hypertrophy (n = 3). Thus, many pediatric Fabry patients report early symptoms, particularly pain. gastrointestinal symptoms, and impaired quality of life. Some children experience major complications during the pediatric years. (Pediatr Res 64: 550-555, 2008)
引用
收藏
页码:550 / 555
页数:6
相关论文
共 22 条
[11]   Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate [J].
Levey, Andrew S. ;
Coresh, Josef ;
Greene, Tom ;
Stevens, Lesley A. ;
Lucy Zhang, Yaping ;
Hendriksen, Stephen ;
Kusek, John W. ;
Van Lente, Frederick .
ANNALS OF INTERNAL MEDICINE, 2006, 145 (04) :247-254
[12]   Enzyme replacement therapy with agalsidase alfa in children with Fabry disease [J].
Ramaswami, U. ;
Wendt, S. ;
Pintos-Morell, G. ;
Parini, R. ;
Whybra, C. ;
Leon Leal, J. A. ;
Santus, F. ;
Beck, M. .
ACTA PAEDIATRICA, 2007, 96 (01) :122-127
[13]   Clinical manifestations of Fabry disease in children: Data from the Fabry outcome survey [J].
Ramaswami, U ;
Whybra, C ;
Parini, R ;
Pintos-Morell, G ;
Mehta, A ;
Sunder-Plassmann, G ;
Widmer, U ;
Beck, M .
ACTA PAEDIATRICA, 2006, 95 (01) :86-92
[14]   The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents [J].
Ries, M ;
Ramaswami, U ;
Parini, R ;
Lindblad, B ;
Whybra, C ;
Willers, I ;
Gal, A ;
Beck, M .
EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (11) :767-772
[15]   Pediatric Fabry disease [J].
Ries, M ;
Gupta, S ;
Moore, DF ;
Sachdev, V ;
Quirk, JM ;
Murray, GJ ;
Rosing, DR ;
Robinson, C ;
Schaefer, E ;
Gal, A ;
Dambrosia, JM ;
Garman, SC ;
Brady, RO ;
Schiffmann, R .
PEDIATRICS, 2005, 115 (03) :E344-E355
[16]   Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease [J].
Ries, Markus ;
Clarke, Joe T. R. ;
Whybra, Catharina ;
Timmons, Margaret ;
Robinson, Chevalia ;
Schlaggar, Bradley L. ;
Pastores, Gregory ;
Lien, Y. Howard ;
Kampmann, Christoph ;
Brady, Roscoe O. ;
Beck, Michael ;
Schiffmann, Raphael .
PEDIATRICS, 2006, 118 (03) :924-932
[17]   Enzyme replacement therapy in Fabry disease - A randomized controlled trial [J].
Schiffmann, R ;
Kopp, JB ;
Austin, HA ;
Sabnis, S ;
Moore, DF ;
Weibel, T ;
Balow, JE ;
Brady, RO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2743-2749
[18]  
SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571
[19]  
Ware J.E., 2003, SF 36 HLTH SURVEY MA
[20]   Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry [J].
Wilcox, William R. ;
Oliveira, Joao Paulo ;
Hopkin, Robert J. ;
Ortiz, Alberto ;
Banikazemi, Maryam ;
Feldt-Rasmussen, Ulla ;
Sims, Katherine ;
Waldek, Stephen ;
Pastores, Gregory M. ;
Lee, Philip ;
Eng, Christine M. ;
Marodi, Laszlo ;
Stanford, Kevin E. ;
Breunig, Frank ;
Wanner, Christoph ;
Warnock, David G. ;
Lemay, Roberta M. ;
Germain, Dominique P. .
MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) :112-128